<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Bax suppresses <z:mp ids='MP_0002006'>tumorigenesis</z:mp> in a mouse model system and Bax-deficient mice exhibit <z:mp ids='MP_0000688'>lymphoid hyperplasia</z:mp> suggesting that BAX functions as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor in human haemopoietic cells </plain></SENT>
<SENT sid="1" pm="."><plain>We examined BAX expression in 20 cell lines derived from human haemopoietic <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> and consistent with a potential <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor function, identified two cell lines, DG75 (a Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line) and Jurkat (a T-cell <z:mpath ids='MPATH_336'>leukaemia</z:mpath> line), which lacked detectable BAX expression </plain></SENT>
<SENT sid="2" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> of DG75 cells induced by low serum or ionomycin was significantly delayed relative to similar Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines with <z:mpath ids='MPATH_458'>normal</z:mpath> BAX levels </plain></SENT>
<SENT sid="3" pm="."><plain>Although DG75 and Jurkat cells expressed several BAX <z:chebi fb="40" ids="33697">RNA</z:chebi> species including the prototypical BAX alpha <z:chebi fb="40" ids="33697">RNA</z:chebi>, the absence of BAX protein was due to single base deletions and additions in a polyguanine tract within the BAX open reading frame </plain></SENT>
<SENT sid="4" pm="."><plain>These frameshift mutations result in premature termination of translation and have recently also been identified in some <z:hpo ids='HP_0003003'>colon cancers</z:hpo> with microsatellite instability </plain></SENT>
<SENT sid="5" pm="."><plain>Although mismatch repair defects are not considered a common feature of haemopoietic <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, DG75 and Jurkat cells had widespread microsatellite instability and did not express detectable levels of MSH2 </plain></SENT>
<SENT sid="6" pm="."><plain>In Jurkat cells, lack of MSH2 expression was due to a point mutation in exon 13 of MSH2 resulting in premature termination of translation </plain></SENT>
<SENT sid="7" pm="."><plain>Our results suggest that a pathway linking mismatch repair defects, BAX <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor frameshift mutations and resistance to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> may be a key feature of some <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and <z:mpath ids='MPATH_336'>leukaemias</z:mpath> </plain></SENT>
</text></document>